Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Cash from Financing Activities (2018 - 2025)

Historic Cash from Financing Activities for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to -$537000.0.

  • Health Catalyst's Cash from Financing Activities fell 10047.74% to -$537000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$197.7 million, marking a year-over-year decrease of 27270.1%. This contributed to the annual value of $151.7 million for FY2024, which is 545846.15% up from last year.
  • According to the latest figures from Q3 2025, Health Catalyst's Cash from Financing Activities is -$537000.0, which was down 10047.74% from -$230.1 million recorded in Q2 2025.
  • Health Catalyst's 5-year Cash from Financing Activities high stood at $248.8 million for Q3 2021, and its period low was -$230.1 million during Q2 2025.
  • For the 5-year period, Health Catalyst's Cash from Financing Activities averaged around $9.5 million, with its median value being $1.0 million (2023).
  • In the last 5 years, Health Catalyst's Cash from Financing Activities surged by 1071682.69% in 2024 and then tumbled by 3306547.28% in 2025.
  • Health Catalyst's Cash from Financing Activities (Quarter) stood at $3.9 million in 2021, then crashed by 83.73% to $637000.0 in 2022, then tumbled by 37.99% to $395000.0 in 2023, then skyrocketed by 9441.77% to $37.7 million in 2024, then plummeted by 101.42% to -$537000.0 in 2025.
  • Its Cash from Financing Activities was -$537000.0 in Q3 2025, compared to -$230.1 million in Q2 2025 and -$4.7 million in Q1 2025.